A Texas woman has filed a lawsuit against the maker of the cholesterol-lowering drug Lipitor alleging the medication increased her risk of developing type 2 diabetes. The lawsuit was filed against Pfizer in the Eastern District of Texas, Marshall Division.
Lipitor is widely prescribed to lower cholesterol and reduce the risk of cardiovascular disease. It is in a class of medications called statins. The plaintiff was prescribed Lipitor in 2006, and was diagnosed with diabetes in 2009. Her lawsuit claims Pfizer did not adequately warn doctors or patients that using the drug increased the risk for type 2 diabetes.
Pfizer is accused of product liability, failure to warn, negligence, breach of implied warranty, fraud and constructive fraud. The plaintiff is seeking damages for medical expenses, compensatory damages for physical and emotional injuries, pain and suffering, economic loss, punitive damages, interest and court costs.
Diabetes is a chronic condition that almost always requires medication to keep blood sugar levels in check. If uncontrolled, diabetes can lead to blindness, heart disease, Alzheimer’s disease, and amputations due to neuropathy. Recent studies have linked Lipitor with type 2 diabetes. Postmenopausal women were at even greater risk of developing the disease.
Attorneys with Beasley Allen Law Firm are currently investigating cases of type 2 diabetes in people who used Lipitor.
Source: SE Texas Record